An AI Foundation Toxicology Model and Framework to Support Waiving a Second Species in Drug Safety Studies

This program funds the development of an AI-driven toxicology model and framework to enable waiving a second animal species in drug safety studies, aiming to improve decision-making, standardise non-animal methods, and reduce animal use in pharmaceutical research. It supports creating validated AI models and weight-of-evidence approaches for regulatory adoption.